[ WP ] Science discovers that the key to immortality is a delicate combination of a number of the most deadly and aggressive terminal diseases known to man . You are the very first immortality prototype .

Trial 1: 
 The subject was placed in a sterilized room. 
 Subject 1 was given AIDS. This was intended to slow down the immune system and give the remaining disease cells time to multiply. 
 The subject's immune system weakened at a faster rate than was intended and the subject expired 27 hours after being infected with the second virus. 
 
 Triak 2: 
 Aids was injected. The patient also received regular doses of antibodies from compatible survivors of the disease. 
 
 The patient was infected with leprosy. The decreased immune response allowed the disease to take hold. 
 Several of the patient's cells were altered to become cancerous and reinfected into the patient. The cancer spread out of control. Chemotherapy was not attempted, as it would have altered the experimental results. The leprosy was not effective in stopping the spread of the cancerous cells. The patient expired 23 days after the insertion of cancerous cells. 
 
 Trial 12: 
 The subject expired from paralysis of the lungs. Brain death occurred before local technicians could arrive at the scene and life support was not attempted. 
 
 Trial 24: 
 The subject expired from self inflicted wounds 103 days after the start of the experiment. Post-mortem brain scans show an enlarged amygdala, indicating high levels of stress, and lesions in the frontal lobe, indicating problems with self control. It is recombined that future subjects be restrained. 
 
 Trial 27: 
 The subject successfully completed the preparation stage and was entered into the testing stage. Blood clotting was slower than in the average human, and the patient expired after the first test. 
 
 Trial 31: 
 The subject entered the testing stage. The subject expired from lack of Oxygen after seven minutes. Carbon dioxide was successfully vented through the skin. 
 
 Trial 37: 
 The subject, originally an 87 year old female, visually and physically mimics the appearance of a twenty year old human except in the brain. In the post-portem, the subject's Alzheimer's disease was still present. 
 
 Trial 49: 
 The subject survived all applied tests, but had to be eliminated by a security team after assaulting and wounding several lab technicians. 
 
 Trial 51: 
 The subject survived all applied tests and was eliminated. The post-mortem revealed the expected results. Public testing will begin soon.
